In cervical cancer, sulforaphane has been found to induce p62 expression and p62 body formation through the transcriptional coactivator SPBP, thereby influencing the activation of cytoprotective autophagy signaling associated with Nrf2 138. Here, NFE2L2 is linked to cervical cancer.